BUDGET-IMPACT ANALYSIS OF ADDING THE NEW 10-VALENT PNEUMOCOCCAL CONJUGATE VACCINATION (PHID-CV) TO ROUTINE INFANT VACCINATION IN CANADA

被引：0
|
作者：
Ismaila, A. S. [1 ]
Pereira, J. A. [1 ]
Robson, R. C. [1 ]
Talbird, S. E. [2 ]
Standaert, B. A. [3 ]
Rawson, N. S. [1 ]
机构：
[1] GlaxoSmithKline Inc, Mississauga, ON, Canada
[2] RTI Hlth Solut, Res Triangle Pk, NC USA
[3] GlaxoSmithKline Biol, Rixensart, Belgium
来源：
VALUE IN HEALTH | 2009年 / 12卷 / 07期
关键词：
D O I：
10.1016/S1098-3015(10)75067-1
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A418 / A418
页数：1
相关论文
共 50 条
  • [1] Cost-effectiveness analysis of infant pneumococcal vaccination with PHiD-CV in Korea
    Zhang, Xu-Hao
    Leeuwenkamp, Oscar
    Oh, Kyu-Bin
    Lee, Young Eun
    Kim, Chul-Min
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2018, 14 (01) : 85 - 94
  • [2] MODELING THE OUTCOMES OF VACCINATION WITH THE 10-VALENT PNEUMOCOCCAL NON-TYPEABLE HAEMOPHILUS INFLUENZAE PROTEIN-D CONJUGATE VACCINE (PHID-CV) IN SPAIN
    Mares, J.
    Moraga-Llop, F.
    Fenoll, A.
    Perez-Alcantara, F.
    Perez, I
    Morano, R.
    VALUE IN HEALTH, 2009, 12 (07) : A426 - A426
  • [3] Impact of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) on pneumococcal disease
    Hausdorff, W.
    Mrkvan, T.
    Moreira, M.
    Guinazu, J. Ruiz
    Borys, D.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2013, 42 : S157 - S157
  • [4] A COST EFFECTIVENESS ANALYSIS OF A GENERAL VACCINATION PROGRAMME WITH THE NEW 10-VALENT PNEUMOCOCCAL NON-TYPEABLE HAEMOPHILUS INFLUENZAE PROTEIN-D CONJUGATE VACCINE (PHID-CV) IN SWEDEN
    Bergman, A.
    Borg, S.
    Sobocki, P.
    Persson, U.
    VALUE IN HEALTH, 2009, 12 (03) : A165 - A165
  • [5] Effects of Vaccination with 10-Valent Pneumococcal Non-Typeable Haemophilus influenza Protein D Conjugate Vaccine (PHiD-CV) on the Nasopharyngeal Microbiome of Kenyan Toddlers
    Feazel, Leah M.
    Santorico, Stephanie A.
    Robertson, Charles E.
    Bashraheil, Mahfudh
    Scott, J. Anthony G.
    Frank, Daniel N.
    Hammitt, Laura L.
    PLOS ONE, 2015, 10 (06):
  • [6] Clinical and Economic Impact of a Potential Switch from 13-Valent to 10-Valent Pneumococcal Conjugate Infant Vaccination in Canada
    Michele Wilson
    Matt Wasserman
    Taj Jadavi
    Maarten Postma
    Marie-Claude Breton
    Francois Peloquin
    Stephanie Earnshaw
    Cheryl McDade
    Heather Sings
    Raymond Farkouh
    Infectious Diseases and Therapy, 2018, 7 : 353 - 371
  • [7] Effectiveness and impact of the 10-valent pneumococcal conjugate vaccine, PHiD-CV: review of clinical trials and post-marketing experience
    Mrkvan, Tomas
    Pelton, Stephen I.
    Ruiz-Guinazu, Javier
    Palmu, Arto A.
    Borys, Dorota
    EXPERT REVIEW OF VACCINES, 2018, 17 (09) : 797 - 818
  • [8] COST EFFECTIVENESS ANALYSIS OF THE NEW 10-VALENT PNEUMOCOCCAL NON-TYPEABLE HAEMOPHILUS INFLUENZAE PROTEIN-D CONJUGATE VACCINE (PHID-CV) IN CANADA
    Ismaila, A. S.
    Pereira, J. A.
    Robson, R. C.
    Simpson, S. D.
    Rawson, N. S.
    Standaert, B. A.
    VALUE IN HEALTH, 2009, 12 (03) : A9 - A9
  • [9] Clinical and Economic Impact of a Potential Switch from 13-Valent to 10-Valent Pneumococcal Conjugate Infant Vaccination in Canada
    Wilson, Michele
    Wasserman, Matt
    Jadavi, Taj
    Postma, Maarten
    Breton, Marie-Claude
    Peloquin, Francois
    Earnshaw, Stephanie
    McDade, Cheryl
    Sings, Heather
    Farkouh, Raymond
    INFECTIOUS DISEASES AND THERAPY, 2018, 7 (03) : 353 - 371
  • [10] Cost-effectiveness analysis of pneumococcal vaccination with PHiD-CV in Korea
    Kim, C. M.
    Leeuwenkamp, O.
    Oh, K. B.
    Zhang, X. H.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2015, 45 : S125 - S125
12345